CN Stock MarketDetailed Quotes

301060 Shanghai Labway Clinical Laboratory

Watchlist
  • 8.93
  • -0.14-1.54%
Noon Break Apr 19 11:30 CST
3.58BMarket Cap297.67P/E (TTM)

Shanghai Labway Clinical Laboratory Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
(Q9)Sep 30, 2021
(Q6)Jun 30, 2021
Total operating revenue
-59.15%1.27B
-59.34%837.91M
-50.15%412.59M
136.14%4.2B
143.91%3.11B
167.17%2.06B
132.24%827.69M
43.62%1.78B
47.57%1.27B
54.10%771.29M
Operating revenue
-59.15%1.27B
-59.34%837.91M
-50.15%412.59M
136.14%4.2B
143.91%3.11B
167.17%2.06B
132.24%827.69M
43.62%1.78B
47.57%1.27B
54.10%771.29M
Other operating revenue
----
-13.28%3.99M
----
46.94%17.5M
----
168.90%4.6M
----
74.30%11.91M
----
-37.37%1.71M
Total operating cost
-45.04%1.2B
-44.73%781.25M
-32.76%368.99M
109.92%3.07B
117.79%2.19B
126.06%1.41B
97.21%548.73M
37.60%1.46B
38.99%1B
47.51%625.21M
Operating cost
-45.16%958.85M
-43.25%622.49M
-32.07%292.61M
119.30%2.41B
126.05%1.75B
129.76%1.1B
97.19%430.73M
31.02%1.1B
34.19%773.42M
43.04%477.38M
Operating tax surcharges
1.10%3.43M
-13.89%1.92M
-16.69%961.53K
10.84%5.47M
-11.87%3.39M
-3.90%2.23M
10.85%1.15M
8.49%4.93M
22.96%3.84M
17.76%2.33M
Operating expense
-48.87%69.82M
-51.93%46.39M
-48.55%21.39M
46.73%184.12M
76.81%136.54M
81.09%96.49M
72.44%41.56M
57.99%125.48M
51.00%77.23M
74.35%53.28M
Administration expense
-44.91%135.35M
-51.66%89.22M
-32.00%42.5M
83.62%355.54M
94.79%245.71M
140.86%184.59M
119.00%62.51M
61.66%193.63M
64.93%126.14M
60.44%76.64M
Financial expense
-60.68%2.06M
3.67%1.59M
180.31%776.06K
625.94%7.64M
564.05%5.23M
377.71%1.53M
309.77%276.85K
249.53%1.05M
329.63%787.51K
1,390.91%320.24K
-Interest expense (Financial expense)
12.18%6.24M
68.39%3.91M
188.46%2.18M
158.98%8.46M
134.66%5.56M
44.46%2.32M
5.20%755.22K
--3.27M
--2.37M
--1.61M
-Interest Income (Financial expense)
-152.15%-4.77M
-101.94%-2.66M
-104.55%-1.4M
-3.35%-2.78M
1.42%-1.89M
10.40%-1.32M
10.35%-684.57K
-113.31%-2.69M
-96.61%-1.92M
-112.38%-1.47M
Research and development
-32.33%32.7M
-38.08%19.63M
-13.92%10.75M
177.38%109.4M
110.16%48.32M
107.76%31.71M
106.19%12.49M
80.91%39.44M
45.06%22.99M
56.25%15.26M
Credit Impairment Loss
-137.64%-74.98M
-346.98%-78.35M
-741.55%-35.52M
-270.01%-54.59M
-176.42%-31.55M
-88.33%-17.53M
21.85%-4.22M
-15.11%-14.75M
-79.05%-11.41M
-37.60%-9.31M
Asset Impairment Loss
-32.48%-8.26M
34.53%-2.7M
65.58%-700.77K
-1,849.87%-136.37M
-95.22%-6.24M
-48.38%-4.12M
-1,234.52%-2.04M
-51.60%-6.99M
10.88%-3.2M
16.12%-2.78M
Other net revenue
-116.76%-62M
-376.27%-62.79M
-2,863.09%-21.06M
-5,082.27%-178.97M
-4,589.90%-28.6M
-619.03%-13.18M
258.28%762.18K
3.41%3.59M
-91.21%637.08K
-39.49%2.54M
Fair value change income
----
--0
--0
-57.66%1.66M
330.88%1.66M
-21.72%1.66M
-5.56%1.66M
647.48%3.93M
-78.22%386.22K
11.91%2.13M
Invest income
-209.13%-2.3M
-163.01%-1.67M
-147.24%-867.04K
-88.01%748.08K
-59.86%2.11M
-19.58%2.64M
419.99%1.84M
-9.38%6.24M
29.43%5.25M
52.06%3.29M
-Including: Investment income associates
-335.47%-2.19M
---1.43M
---766.56K
---1.61M
---503.51K
----
----
----
----
----
Asset deal income
513.54%1.5M
-612.09%-682.49K
-494.41%-300.95K
-135.03%-363.15K
-71.44%244.58K
-72.03%133.28K
--76.3K
58.85%1.04M
44.66%856.38K
-13.27%476.52K
Other revenue
326.28%22.03M
411.61%20.6M
374.26%16.33M
-29.67%9.94M
-40.97%5.17M
-53.91%4.03M
16.45%3.44M
10.06%14.13M
-18.81%8.76M
-9.60%8.74M
Operating profit
-99.36%5.67M
-100.97%-6.13M
-91.94%22.54M
197.63%949.28M
229.64%892.73M
326.66%634.09M
260.16%279.73M
78.72%318.95M
82.55%270.82M
83.75%148.62M
Add:Non operating Income
60.04%200.78K
109.73%156.47K
-14.70%67.55K
-18.73%1.59M
-93.35%125.45K
-59.11%74.61K
8,305.05%79.19K
249.50%1.96M
255.43%1.89M
-64.96%182.43K
Less:Non operating expense
-58.05%5.36M
-11.47%5.16M
-5.33%2.98M
1,516.95%46.42M
689.92%12.77M
696.79%5.82M
933.90%3.15M
-82.83%2.87M
-88.53%1.62M
-92.99%730.95K
Total profit
-99.94%513.85K
-101.77%-11.13M
-92.91%19.63M
184.39%904.44M
224.65%880.08M
324.35%628.34M
257.60%276.65M
95.94%318.03M
101.13%271.09M
108.63%148.07M
Less:Income tax cost
-93.29%9.88M
-93.44%6.67M
-91.13%4.04M
193.17%165.39M
219.97%147.16M
285.29%101.63M
245.04%45.5M
102.73%56.41M
85.18%45.99M
124.66%26.38M
Net profit
SL-9.37M
SL-17.8M
-93.26%15.59M
182.50%739.06M
225.61%732.92M
332.82%526.71M
260.18%231.16M
94.54%261.62M
104.73%225.1M
105.45%121.69M
Net profit from continuing operation
-101.28%-9.37M
-103.38%-17.8M
-93.26%15.59M
182.50%739.06M
225.61%732.92M
332.82%526.71M
260.18%231.16M
94.54%261.62M
104.73%225.1M
105.45%121.69M
Less:Minority Profit
-106.60%-8.49M
-116.61%-15.97M
-110.80%-5.82M
110.70%121.73M
169.42%128.6M
309.00%96.16M
396.58%53.92M
139.69%57.78M
179.02%47.73M
90.00%23.51M
Net profit of parent company owners
-100.15%-880.08K
-100.42%-1.82M
-87.92%21.41M
202.85%617.32M
240.73%604.32M
338.53%430.55M
232.41%177.24M
84.68%203.84M
91.04%177.36M
109.53%98.18M
Earning per share
Basic earning per share
-100.15%-0.0022
-100.43%-0.0046
-87.91%0.0535
166.52%1.5413
199.84%1.5088
285.86%1.075
192.47%0.4425
84.64%0.5783
91.04%0.5032
109.63%0.2786
Diluted earning per share
-100.15%-0.0022
-100.43%-0.0046
-87.91%0.0535
166.52%1.5413
199.84%1.5088
285.86%1.075
192.47%0.4425
84.64%0.5783
91.04%0.5032
109.63%0.2786
Other composite income
Total composite income
-101.28%-9.37M
-103.38%-17.8M
-93.26%15.59M
182.50%739.06M
225.61%732.92M
332.82%526.71M
260.18%231.16M
94.54%261.62M
104.73%225.1M
105.45%121.69M
Total composite income of parent company owners
-100.15%-880.08K
-100.42%-1.82M
-87.92%21.41M
202.85%617.32M
240.73%604.32M
338.53%430.55M
232.41%177.24M
84.68%203.84M
91.04%177.36M
109.53%98.18M
Total composite income of minority owners
-106.60%-8.49M
-116.61%-15.97M
-110.80%-5.82M
110.70%121.73M
169.42%128.6M
309.00%96.16M
396.58%53.92M
139.69%57.78M
179.02%47.73M
90.00%23.51M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Rong Shing Certified Public Accountants (Special General Partnership)
--
--
--
Rong Shing Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021(Q9)Sep 30, 2021(Q6)Jun 30, 2021
Total operating revenue -59.15%1.27B-59.34%837.91M-50.15%412.59M136.14%4.2B143.91%3.11B167.17%2.06B132.24%827.69M43.62%1.78B47.57%1.27B54.10%771.29M
Operating revenue -59.15%1.27B-59.34%837.91M-50.15%412.59M136.14%4.2B143.91%3.11B167.17%2.06B132.24%827.69M43.62%1.78B47.57%1.27B54.10%771.29M
Other operating revenue -----13.28%3.99M----46.94%17.5M----168.90%4.6M----74.30%11.91M-----37.37%1.71M
Total operating cost -45.04%1.2B-44.73%781.25M-32.76%368.99M109.92%3.07B117.79%2.19B126.06%1.41B97.21%548.73M37.60%1.46B38.99%1B47.51%625.21M
Operating cost -45.16%958.85M-43.25%622.49M-32.07%292.61M119.30%2.41B126.05%1.75B129.76%1.1B97.19%430.73M31.02%1.1B34.19%773.42M43.04%477.38M
Operating tax surcharges 1.10%3.43M-13.89%1.92M-16.69%961.53K10.84%5.47M-11.87%3.39M-3.90%2.23M10.85%1.15M8.49%4.93M22.96%3.84M17.76%2.33M
Operating expense -48.87%69.82M-51.93%46.39M-48.55%21.39M46.73%184.12M76.81%136.54M81.09%96.49M72.44%41.56M57.99%125.48M51.00%77.23M74.35%53.28M
Administration expense -44.91%135.35M-51.66%89.22M-32.00%42.5M83.62%355.54M94.79%245.71M140.86%184.59M119.00%62.51M61.66%193.63M64.93%126.14M60.44%76.64M
Financial expense -60.68%2.06M3.67%1.59M180.31%776.06K625.94%7.64M564.05%5.23M377.71%1.53M309.77%276.85K249.53%1.05M329.63%787.51K1,390.91%320.24K
-Interest expense (Financial expense) 12.18%6.24M68.39%3.91M188.46%2.18M158.98%8.46M134.66%5.56M44.46%2.32M5.20%755.22K--3.27M--2.37M--1.61M
-Interest Income (Financial expense) -152.15%-4.77M-101.94%-2.66M-104.55%-1.4M-3.35%-2.78M1.42%-1.89M10.40%-1.32M10.35%-684.57K-113.31%-2.69M-96.61%-1.92M-112.38%-1.47M
Research and development -32.33%32.7M-38.08%19.63M-13.92%10.75M177.38%109.4M110.16%48.32M107.76%31.71M106.19%12.49M80.91%39.44M45.06%22.99M56.25%15.26M
Credit Impairment Loss -137.64%-74.98M-346.98%-78.35M-741.55%-35.52M-270.01%-54.59M-176.42%-31.55M-88.33%-17.53M21.85%-4.22M-15.11%-14.75M-79.05%-11.41M-37.60%-9.31M
Asset Impairment Loss -32.48%-8.26M34.53%-2.7M65.58%-700.77K-1,849.87%-136.37M-95.22%-6.24M-48.38%-4.12M-1,234.52%-2.04M-51.60%-6.99M10.88%-3.2M16.12%-2.78M
Other net revenue -116.76%-62M-376.27%-62.79M-2,863.09%-21.06M-5,082.27%-178.97M-4,589.90%-28.6M-619.03%-13.18M258.28%762.18K3.41%3.59M-91.21%637.08K-39.49%2.54M
Fair value change income ------0--0-57.66%1.66M330.88%1.66M-21.72%1.66M-5.56%1.66M647.48%3.93M-78.22%386.22K11.91%2.13M
Invest income -209.13%-2.3M-163.01%-1.67M-147.24%-867.04K-88.01%748.08K-59.86%2.11M-19.58%2.64M419.99%1.84M-9.38%6.24M29.43%5.25M52.06%3.29M
-Including: Investment income associates -335.47%-2.19M---1.43M---766.56K---1.61M---503.51K--------------------
Asset deal income 513.54%1.5M-612.09%-682.49K-494.41%-300.95K-135.03%-363.15K-71.44%244.58K-72.03%133.28K--76.3K58.85%1.04M44.66%856.38K-13.27%476.52K
Other revenue 326.28%22.03M411.61%20.6M374.26%16.33M-29.67%9.94M-40.97%5.17M-53.91%4.03M16.45%3.44M10.06%14.13M-18.81%8.76M-9.60%8.74M
Operating profit -99.36%5.67M-100.97%-6.13M-91.94%22.54M197.63%949.28M229.64%892.73M326.66%634.09M260.16%279.73M78.72%318.95M82.55%270.82M83.75%148.62M
Add:Non operating Income 60.04%200.78K109.73%156.47K-14.70%67.55K-18.73%1.59M-93.35%125.45K-59.11%74.61K8,305.05%79.19K249.50%1.96M255.43%1.89M-64.96%182.43K
Less:Non operating expense -58.05%5.36M-11.47%5.16M-5.33%2.98M1,516.95%46.42M689.92%12.77M696.79%5.82M933.90%3.15M-82.83%2.87M-88.53%1.62M-92.99%730.95K
Total profit -99.94%513.85K-101.77%-11.13M-92.91%19.63M184.39%904.44M224.65%880.08M324.35%628.34M257.60%276.65M95.94%318.03M101.13%271.09M108.63%148.07M
Less:Income tax cost -93.29%9.88M-93.44%6.67M-91.13%4.04M193.17%165.39M219.97%147.16M285.29%101.63M245.04%45.5M102.73%56.41M85.18%45.99M124.66%26.38M
Net profit SL-9.37MSL-17.8M-93.26%15.59M182.50%739.06M225.61%732.92M332.82%526.71M260.18%231.16M94.54%261.62M104.73%225.1M105.45%121.69M
Net profit from continuing operation -101.28%-9.37M-103.38%-17.8M-93.26%15.59M182.50%739.06M225.61%732.92M332.82%526.71M260.18%231.16M94.54%261.62M104.73%225.1M105.45%121.69M
Less:Minority Profit -106.60%-8.49M-116.61%-15.97M-110.80%-5.82M110.70%121.73M169.42%128.6M309.00%96.16M396.58%53.92M139.69%57.78M179.02%47.73M90.00%23.51M
Net profit of parent company owners -100.15%-880.08K-100.42%-1.82M-87.92%21.41M202.85%617.32M240.73%604.32M338.53%430.55M232.41%177.24M84.68%203.84M91.04%177.36M109.53%98.18M
Earning per share
Basic earning per share -100.15%-0.0022-100.43%-0.0046-87.91%0.0535166.52%1.5413199.84%1.5088285.86%1.075192.47%0.442584.64%0.578391.04%0.5032109.63%0.2786
Diluted earning per share -100.15%-0.0022-100.43%-0.0046-87.91%0.0535166.52%1.5413199.84%1.5088285.86%1.075192.47%0.442584.64%0.578391.04%0.5032109.63%0.2786
Other composite income
Total composite income -101.28%-9.37M-103.38%-17.8M-93.26%15.59M182.50%739.06M225.61%732.92M332.82%526.71M260.18%231.16M94.54%261.62M104.73%225.1M105.45%121.69M
Total composite income of parent company owners -100.15%-880.08K-100.42%-1.82M-87.92%21.41M202.85%617.32M240.73%604.32M338.53%430.55M232.41%177.24M84.68%203.84M91.04%177.36M109.53%98.18M
Total composite income of minority owners -106.60%-8.49M-116.61%-15.97M-110.80%-5.82M110.70%121.73M169.42%128.6M309.00%96.16M396.58%53.92M139.69%57.78M179.02%47.73M90.00%23.51M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Rong Shing Certified Public Accountants (Special General Partnership)------Rong Shing Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg